Clinical Trial

Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome

Name: Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome — clinical trial record (NCT06519162)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: LGAS

Recruiting

View on ClinicalTrials.gov →

Summary

In this study, we aim to identify gut microbiomes specific to patients with chronic refractory liver disease and to conduct a gut-liver axis study on the pathogenesis and disease progression.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2024-07-22.

Trial Details

NCT Number	NCT06519162
Lead Sponsor	Chungnam National University Hospital Collaborators: Chungnam National University
Conditions	Autoimmune Hepatitis, Primary Sclerosing Cholangitis, Non-Alcoholic Fatty Liver Disease, Liver Abscess, Primary Biliary Cirrhosis
Enrollment	3,000 participants
Start Date	2024-07-08
Primary Completion	2029-07-08 (estimated)
Study Completion	2029-07-08 (estimated)
Updated on ClinicalTrials.gov	2026-03-20